4-iodophenylboronic acid: structure given in first source; selectively concentrates in some cancer cells
ID Source | ID |
---|---|
PubMed CID | 151254 |
SCHEMBL ID | 49312 |
MeSH ID | M0214969 |
Synonym |
---|
AC-5368 |
5122-99-6 |
4-iodophenylboronic acid |
4-iodophenylboronic acid, >=95.0% |
(4-iodophenyl)boronic acid |
A7570 |
AKOS005255103 |
benzeneboronic acid, p-iodo- |
p-iodobenzeneboronic acid |
I0830 |
4-iodobenzeneboronic acid |
p-iodophenylboronic acid |
FT-0618804 |
AS-2311 |
AM20050274 |
AB08832 |
SCHEMBL49312 |
4-iodo phenyl boronic acid |
PELJYVULHLKXFF-UHFFFAOYSA-N |
mfcd01319014 |
SY022131 |
p-iodophenylboromc acid |
boronic acid, (4-iodophenyl)- |
J-515576 |
DTXSID50199231 |
CS-W002769 |
STL554615 |
4-iodophenylboronic acid (contains varying amounts of anhydride) |
1-(4-methylphenyl)-1-cyclopropanecarboxylicacid,98 |
(4-iodophenyl)boronicacid |
BBL100821 |
b-(4-iodophenyl)-boronic acid |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (22.98) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |